PRIMARY
AIM:
Examine the effectiveness of extended cognitive behavior therapy (CBT) in promoting longer-term smoking abstinence.
DESIGN:
Open-label treatment phase followed by extended treatment phase.
Randomization conducted prior to entry into open-label treatment phase; analysis based on intention-to-treat to avoid threat of selection bias.
SETTING:
Community smoking cessation clinic.
PARTICIPANTS:
A total of 304 adult smokers (> or = 18 years of age; > or = 10 cigarettes/day).
INTERVENTION:
Open-label (8 weeks): all participants received bupropion SR, nicotine patch, CBT. Extended treatment (12 weeks): participants received either CBT + voicemail monitoring and telephone counseling or telephone-based general support.
MEASUREMENTS:
Seven-day point prevalence abstinence, expired-air carbon monoxide.
RESULTS:
At week 20 follow-up, CBT produced a higher 7-day point prevalence abstinence rate: 45% versus 29%, P = 0.006; at 52 weeks the difference in abstinence rates (31% versus 27%) was not significant.
History of depression was a moderator of treatment.
Those with a positive history had a better treatment response at 20 weeks when assigned to the less intensive telephone support therapy (P < 0.05).
CONCLUSION:
The superiority of CBT to 20 weeks suggests that continued emphasis on the development of cognitive and behavioral strategies for maintaining non-smoking during an extended treatment phase may help smokers to maintain abstinence in the longer term.
At present, the minimum duration of therapy is unknown.
2008-10-15
Eng.
Addiction (Abingdon, England)
Stanford University School of Medicine, Stanford, CA 94305-5705, USA. jkillen [at] stanford.edu
Addiction. 2008 Aug;103(8):1381-90
© Galenicom 1999-2013